News
The basic MedRing patent is granted in China
Stunning results LiGalli first in human study
See press release here.
The MedRing Alpha 1.0 is ready
The first in-human trials will start shortly.
The basic MedRing patent is granted
First in the EU, later also in the US
The MedRing functional model is ready
Watch the video on the page “How it works.”
The Dutch Government awards LiGalli the MIT subsidy
We look forward to working with our new partner Gimix.
What's new
If you had to guess, which is more common in women—diabetes or endometriosis? It’s a trick question. They actually affect women equally. However, endometriosis receives $1 of research funding for every $200 invested in diabetes.
While there may be various explanations for this discrepancy, there’s a long pattern of health care providers, venture capitalists, and science…